Table 1.
In vitro stimulation | [3H]Thymidine incorporation, cpm
|
|
---|---|---|
Normal mice | A20HA-bearing mice | |
None | 3,026 ± 635 | 3,268 ± 1,203 |
HA peptide* | 44,864 ± 9,168 | 11,155 ± 3,746 |
Vaccinia-infected splenocytes† | 16,133 ± 2,307 | 17,359 ± 3,532 |
Con A‡ | 72,511 ± 10,204 | 59,115 ± 15,786 |
HA + IL-2§ | 64,114 ± 10,891 | 41,800 ± 4,177 |
BALB/c mice were given 1 × 106 A20HA tumor cells intravenously or received no tumor. Nine days later, all mice received 2.5 × 106 anti-HA/I-Ed TCR+ transgenic T cells. Nine days after T cell transfer, all mice were immunized with vacc-HA as in Fig. 4. On day +22 after T cell transfer, the mice were sacrificed and T cells were purified as before. Purified cells (4 × 104 per well) were added to BALB/c splenocytes (8 × 104 per well) and cultured with media alone or with the indicated stimulation. Con A stimulation was done without the addition of BALB/c splenocytes. [3H]Thymidine incorporation was determined after 3 days in culture. Values represent mean ± SE of triplicate cultures.
HA peptide was 12.5 μg/ml.
Normal BALB/c splenocytes were infected with vaccinia virus (3 pfu per cell) for 6 hr. Infected cells were washed three times and then cultured with purified T cells at different stimulator/responder ratios. Values represent proliferation at a ratio of 2:1.
Con A was 50 μg/ml.
HA peptide at 12.5 μg/ml + IL-2 at 20 units/ml.